"We just don't know yet." What you should do If you have PAD, you might be wondering if it's time to ask your doctor about taking a GLP-1 drug
1 There were 2 propensity-matched cohorts with documented cases of coronary plaque who were identified using the TriNetX electronic medical record network between January 1, 2022, and December 31, 2024
The office checks the denial reason usually one of a small set and either resubmits with the missing documentation or asks the patient to schedule a follow-up to gather what was missing the first time
If you need treatment now, semaglutide and tirzepatide are excellent options with strong data behind them
If youre using a nontraditional treatment like a GLP-1 agonist, make sure your condition remains well-controlled and that your physician closely monitors your progress
These injectable drugs are making a big impact